Cargando…
Monoclonal Antibodies as an Antibacterial Approach Against Bacterial Pathogens
In the beginning of the 21st century, the frequency of antimicrobial resistance (AMR) has reached an apex, where even 4th and 5th generation antibiotics are becoming useless in clinical settings. In turn, patients are suffering from once-curable infections, with increases in morbidity and mortality....
Autores principales: | Zurawski, Daniel V., McLendon, Molly K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235762/ https://www.ncbi.nlm.nih.gov/pubmed/32244733 http://dx.doi.org/10.3390/antibiotics9040155 |
Ejemplares similares
-
Monoclonal Antibodies for Bacterial Pathogens: Mechanisms of Action and Engineering Approaches for Enhanced Effector Functions
por: Vacca, Fabiola, et al.
Publicado: (2022) -
I-TRAP: A method to identify transcriptional regulator activated promoters
por: McLendon, Molly M, et al.
Publicado: (2003) -
Novel monoclonal antibodies against pathogenic Leptospira
por: de Matos, Bruno Moisés, et al.
Publicado: (2014) -
Recent Advances in Monoclonal Antibody-Based Approaches in the Management of Bacterial Sepsis
por: Kharga, Kusum, et al.
Publicado: (2023) -
Glioblastoma Stem Cells: A Neuropathologist's View
por: McLendon, Roger E., et al.
Publicado: (2011)